In this interview Dr. Hedmann discusses research published in the Journal of Natural Products regarding Cannabinoids blocking cellular entry of Covid-19. Research showed CBDA and CBGA prevented infection of human epithelial cells by a Covid-19 spike protein. These cannabinoids were equally effective against Covid-19 variants. Link to the published research is below.

Dr. Hedmann also explains the downsides to inhalation vs edibles, the most effective ways to use cannabis, what is bioavailability, and cannabis as it relates to Covid-19 symptoms.

https://pubmed.ncbi.nlm.nih.gov/35007072/

https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c00946

source